FDA Drug Approval Process (Rebroadcast)

Sunday, August 22, 2010 - 2:06 p.m.
FDA Drug Approval Process (Rebroadcast)

An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA's accelerated approval process to treat serious and life threatening diseases.

An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA's accelerated approval process to treat serious and life threatening diseases.

Guests

Gardiner Harris

science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Dr. Carolyn Hendricks

a medical oncologist affiliated with Suburban Hospital in Bethesda.

William Hubbard

former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA

Dr. Peter Bach

attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.

This is a rebroadcast. Please view the original broadcast to comment.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.